Can overall survival be improved in elderly multiple myeloma patients?

The ongoing introduction of novel therapies for MM provides clinicians and patients various treatment options in numerous lines of treatment. Understanding the current treatment practices and the corresponding outcomes in different age groups is of vital importance to understand whether these new treatments should be used in patients from all age groups and where options

Lees meer

Trial efficacy vs real world effectiveness in multiple myeloma

Real world evidence (RWE) is increasingly important in guiding reimbursement, but also treatment decisions, as HTAs, health insurers and clinicians are increasingly interested in the true real world (relative) effectiveness rather than the trials’ ideal (relative) efficacy. This requires combining and or comparing RWE effectiveness data with efficacy trial data. The primary aim of the

Lees meer

Welcome Lewis to Ingress-health

Sze Chim (Lewis) obtained a  PhD (Dr. rer. nat.) in Biology from Eberhard Karls Universität Tübingen, Germany. His dissertation topic was to characterize the auditory phenotypes of mice with specific genetic mutations. He has also a Master (MSc) degree in Psychological Research Methods from Lancaster, UK. His PhD study in Tübingen involved performing pre-clinical studies to look for

Lees meer